Organization · Venture Capital
Healthequity, SCR
Healthequity S.C.R., S.A. is a Barcelona-based venture capital firm focused on early-stage healthcare companies, including biotechnology and medical devices.
Overview
What Healthequity, SCR does
What Healthequity, SCR is
Healthequity S.C.R., S.A. is a Barcelona-based venture capital firm focused on early-stage healthcare companies, including biotechnology and medical devices.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Healthequity, SCR elsewhere
Open the official website or a supported primary organization account.
Capability profile
Healthequity, SCR as a funder
Investment thesis
Healthequity S.C.R. focuses on early-stage healthcare innovation, targeting biotechnology, medical devices, and healthcare services to strengthen the Catalan and Spanish biotech ecosystem.
Focus narrative
Healthequity invests primarily in early-stage healthcare companies, focusing on sectors such as biotechnology, medical devices, and healthcare services. The firm is committed to fostering innovation within the healthcare landscape, particularly in Spain and Catalonia.
Value beyond capital
Healthequity provides not only financial support but also strategic guidance and connections within the healthcare ecosystem, leveraging its partnerships with the Barcelona medical community to enhance the growth and success of its portfolio companies.
Terms and economics
- Typical check
- $500,000–$1,000,000
Focus and fit
- Stages
- Seed · Seed+
- Regions
- Europe
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Peptomyc: A company focused on cancer drug discovery, Healthequity led a €1M seed round in April 2016. Minoryx Therapeutics: Specializes in treatments for rare neurological diseases, with a €750K investment from Healthequity. n-Life Therapeutics: Listed as a portfolio company. Sanifit: Focuses on kidney disease and calcification, also part of Healthequity's portfolio.
Common questions
What to know about Healthequity, SCR
Upseed classifies Healthequity, SCR under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.